NV-A01
/ Nanjing Nuowei Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 05, 2024
The Safety and Effectiveness of NV-A01 in Glioma Patients
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: First Affiliated Hospital of Wannan Medical College
Metastases • New P1 trial • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1